This paper develops a case study approach that builds on the foundations of moderate constructionism and abduction. We discuss the case study method and its role in industrial marketing, especially in business-to-business networks. Moderate constructionism is compared with realist, critical realist, and relativist approaches. We argue that moderate constructionism takes better into account the multiple constructed, community-bounded realities that all case studies inevitably deal with. The power of moderate constructionism to produce valid and generalizable new knowledge is critically assessed. We also address abduction in relation to induction and deduction and its role in the moderate constructionist research approach. Finally, we develop a process model, illustrated by a case study of a specific network in the pharmaceutical industry.

Question 1

What false-positive factors could cause ketone bodies to appear in the

urine in a non-diabetic patient?`l415019

Question 2

Why is tetanus not seen in a diabetic foot wound?

Question 3

Can impaired glucose tolerance cause recurrent lower motor facial palsy?

Question 4

Can long-term diabetes mellitus cause vertigo not accompanied by other

brainstem signs?

Question 5

We know that type 2 diabetes mellitus provokes left ventricular diastolic

dysfunction. Does chronic stable angina, associated with type 2 diabetes

mellitus, further increase the prevalence of left ventricular diastolic

dysfunction?

Question 6

Is there adequate evidence for choosing an angiotensin-converting

enzyme (ACE) inhibitor or antagonist for the initial management of

raised blood pressure in type 2 diabetes, or is it now advisable to choose

any tolerated antihypertensive?

Question 7

Why is there immunosuppression in diabetes?

Question 8

Dextrose infusion in quinine induced hypoglycaemia causes more

hypoglycaemia, so what is to be used?

Question 9

Does the serum cholesterol level rise with age?

Question 10

Please explain the significance of having normal total high-density

lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol but a

raised lipoprotein (a) [Lp(a)] in a normotensive, non-smoking patient?